Randomized, Double-blind, Active-controlled, Multicenter, Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of Botulax as Compared to Botox in Subject With Moderate to Severe Crow's Feet Lines
Latest Information Update: 18 Apr 2022
At a glance
- Drugs Letibotulinumtoxina (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Hugel
- 14 Apr 2022 Status changed from recruiting to completed.
- 25 Jan 2018 New trial record
- 24 Jan 2018 Status changed from active, no longer recruiting to recruiting.